Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2005
11/09/2005EP1592424A1 Cabergoline for the prophylactic treatment of migraine
11/09/2005EP1592423A2 Combination therapy of zd6474 with 5-fu and/or cpt-11
11/09/2005EP1592422A2 New pharmaceutical compositions based on anticholinergics and inhibitors of tnf alpha synthesis or action
11/09/2005EP1592421A1 Heteroarylalkanoic acids as integrin receptor antagonists
11/09/2005EP1592420A1 Clindamycin phosphate foam
11/09/2005EP1592419A1 Use of phosphodiesterase-4 inhibitors as enhancers of cognition
11/09/2005EP1592418A2 Use in therapy of endocannabinoid-like compounds
11/09/2005EP1592417A1 Combination of antidiabetic drugs
11/09/2005EP1592416A1 Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis
11/09/2005EP1592415A2 Therapeutically active compounds
11/09/2005EP1592414A1 Injectable liquid formulation of paracetamol
11/09/2005EP1592413A2 Compositions and methods for improving recovery after general anesthesia
11/09/2005EP1592412A1 Down-regulation of target-gene with pei/single-stranded oligoribonucleotide complexes
11/09/2005EP1592411A2 Controlled release of highly soluble agents
11/09/2005EP1592409A2 Use of edible acid in fast-dispersing pharmaceutical solid dosage forms
11/09/2005EP1592408A2 Sustained release device and method for ocular delivery of adrenergic agents
11/09/2005EP1592407A2 Sustained release device and method for ocular delivery of carbonic anhydrase inhibitors
11/09/2005EP1592405A1 Composition for chemoembolotherapy of solid tumors
11/09/2005EP1592399A1 Solid amorphous mixtures, processes for the preparation thereof and pharmaceutical compositions containing the same
11/09/2005EP1592391A2 Tra16 a tr4/tr2 repressor
11/09/2005EP1592390A2 Enhanced bioavailability of nutrients, pharmaceutical agents, and other bioactive substances through laser resonant homogenization or modification of molecular shape or crystalline form
11/09/2005EP1592389A2 Piperazine-2-carboxamide derivatives
11/09/2005EP1592388A2 Methods for diagnosis anf monitoring of neurological disease by detection of an encephalotoxin
11/09/2005EP1592387A2 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents
11/09/2005EP1592386A2 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents
11/09/2005EP1592384A2 Cop 1 for treatment of inflammatory bowel diseases
11/09/2005EP1592383A2 Methods for reducing mortality associated with acute myocardial infarction
11/09/2005EP1592373A2 Freeze-dried fibrin matrices and methods for preparation thereof
11/09/2005EP1592313A1 Infant formula supplemented with phospholipids
11/09/2005EP1592302A2 Methods and compositions related to irm compounds and toll-like receptor 8
11/09/2005EP1511726B1 Method for preparing 1,3,5-triaminobenzene and hydrolyzing it into high-purity phloroglucinol
11/09/2005EP1501787B1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists
11/09/2005EP1480983B1 Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropydimido[1,2-a]pyrimidin-4-one derivatives
11/09/2005EP1480981B1 1-(alkyl), 1-(heteroaryl)alkyl and 1-[(aryl)alkyl]-7-(pyrimidin-4-yl)-imidazo[1,2-a]pyrimidin-5(1h)-one derivatives
11/09/2005EP1476433B1 Novel tricycloimidazoline derivatives, method for production and use thereof as medicaments
11/09/2005EP1456202B1 Benzothiazoles
11/09/2005EP1427734B1 GLYCINE-SUBSTITUTED THIENO[2,3-d]PYRIMIDINES WITH COMBINED LH AND FSH AGONISTIC ACTIVITY
11/09/2005EP1423378B1 Aminopyrrole compounds as antiinflammatory agents
11/09/2005EP1419163B9 Tricyclic imidazopyridines
11/09/2005EP1418891B1 Anaesthetic formulations of propofol
11/09/2005EP1411935A4 Use of 4- (4-thiazolyl)phenoxl] alkoxy-benzamidine derivatives for treatment of osteoporosis
11/09/2005EP1390369B1 4-amino-5-phenyl-7-cyclobutyl-pyrrolo(2,3-d)pyrimidine derivatives
11/09/2005EP1377585B1 Novel 10-cyclohexenyl-phenyl pyrrolobenzodiazepine-3-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists
11/09/2005EP1368025B1 Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor
11/09/2005EP1365748B1 Particulate composition of eletriptan hydrobromide showing a sigmoidal pattern of controlled release
11/09/2005EP1337220A4 Compositions having comfrey and methods for reducing retinoid-induced skin irritation
11/09/2005EP1328552A4 Crosslinked amide derivatives of hyaluronic acid and manufacturing method thereof
11/09/2005EP1315714B1 Quinazoline derivatives as alpha-1 adrenergic antagonists
11/09/2005EP1313700B1 10-aryl-11h-benzo[b]fluorene derivatives and analogs as estrogenic compounds
11/09/2005EP1309349B1 Pharmaceutical composition and method for the treatment of retroviral infections
11/09/2005EP1307196A4 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
11/09/2005EP1282393B1 External application for enhancing the skin permeability of the active components therein
11/09/2005EP1278729B1 Benzosuberonylpiperidine compounds as analgesics
11/09/2005EP1261259B1 Treatment of infection in animals
11/09/2005EP1259514B9 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors
11/09/2005EP1255541B1 Aromatic guanylhydrazone for the treatment of resistant viral infections
11/09/2005EP1254118B1 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives
11/09/2005EP1220932B1 Human carboxypeptidases and polynucleotides encoding the same
11/09/2005EP1218376B1 Tyrosine kinase inhibitors
11/09/2005EP1218366B8 Method for producing cox-2 inhibitors
11/09/2005EP1216223B1 Novel dicarboxylic acid derivatives with pharmaceutical properties
11/09/2005EP1214325B1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases)
11/09/2005EP1212421B1 Gas1 polypeptides
11/09/2005EP1212296B1 Phosphate mimics and methods of treatment using phosphatase inhibitors
11/09/2005EP1212069B1 Improved topical compositions containing extracellular products of probiotic bacteria and uses thereof
11/09/2005EP1204669B1 Tricyclic monosaccharide derivatives useful in treating acute ischemia-induced neurodegeneration
11/09/2005EP1202974B1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/09/2005EP1196403B1 Antipsychotic cyclic n-aralkyl amines
11/09/2005EP1189605B1 High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof
11/09/2005EP1179341B1 Remedies or preventives for diseases in association with chemokines
11/09/2005EP1173218B1 Mucosally adhesive compositions for the treatment of disorders of the oesophagus and their use.
11/09/2005EP1165576B1 Process for preparing amine platinum complexes
11/09/2005EP1163236B1 Aromatic heterocyclic compounds as anti-inflammatory agents
11/09/2005EP1154692B1 A method of controlling fungal pathogens, and agents useful for same
11/09/2005EP1144371B1 Benzenesulphonamide derivatives and their use as mek inhibitors
11/09/2005EP1141245B1 Somatic cells with ablated prp gene and methods of use
11/09/2005EP1130964B1 Therapeutic anti-fungal nail preparation
11/09/2005EP1123701B1 Use of natural physiologically active substances against fish parasitic diseases
11/09/2005EP1111048B1 Neutral amino acid transporter and gene thereof
11/09/2005EP1100788B1 Substituted quinazoline derivatives
11/09/2005EP1096918B1 Skin and tissue care and/or treatment agent
11/09/2005EP1095016B1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
11/09/2005EP1089973B1 Amidino and guanidino azetidinone tryptase inhibitors
11/09/2005EP1087747B1 Foaming composition for hair care
11/09/2005EP1066266B1 Cyclin dependent kinase inhibitors
11/09/2005EP1066041B1 THE USE OF17-ALPHA-ESTRADIOL DERIVATIVES FOR TREATING SIDE-EFFECTS DURING AND/OR AFTER GnRHa THERAPY
11/09/2005EP1049700B1 Chemokine receptor antagonists and methods of use therefor
11/09/2005EP1043982B1 Lipase inhibiting polymers
11/09/2005EP1042275B1 Anticonvulsant and central nervous system-active bis(fluorophenyl)alkylamides
11/09/2005EP1030653B1 Dinitroaniline liposomal formulations and processes for their preparation
11/09/2005EP1029456B1 Foods for preventing vomiting
11/09/2005EP1019392B1 Tricyclic amides useful for inhibition of g-protein function and for treatment of proliferative diseases
11/09/2005EP1019389B1 Epothilone derivatives
11/09/2005EP1011722B1 Substrates materials with bound cytokine-stimulating polysaccharides or bacterial nucleic acids
11/09/2005EP0988285B1 Prodrug forms of ribonucleotide reductase inhibitors 3-ap and 3-amp
11/09/2005EP0979226B1 Isoxazole derivatives
11/09/2005EP0971745B1 Gel delivery vehicles for anticellular proliferative agents
11/09/2005EP0943008B1 Metal mediated serine protease inhibitors
11/09/2005EP0929521B1 Nmda (n-methyl-d-aspartate) antagonists
11/09/2005EP0928290B9 Oligoribonucleotides and ribonucleases for cleaving rna
1 ... 4476 4477 4478 4479 4480 4481 4482 4483 4484 4485 4486 4487 4488 4489 4490 4491 4492 4493 4494 4495 4496 ... 7860